The Virtual Hamilton FHT Pharmacist

Thursday, March 8, 2012

Subscribe to: Comments (Atom)

Update on OxyContin & OxyNEO

Effective March 1, 2012 Purdue Pharma is withdrawing its current formulation of oxycodone controlled release tablet, OxyContin, and intro...
Caring for Patients with Dementia and Diabetes

ADA 2012 Conference, presented by Jamehl Demons, MD - Diabetes – Risk factor for cognitive impairment o Known risk factors...
Clinical Aspects of Hypoglycemia in Diabetes – Consequences and Prevention
Approach to management of hyperglycemia Figure
Implementing a Hyperglycemic Management Program for Complex Older Patients

ADA 2012 Conference, presented by Barbara Resnick, MD - General principles of diabetes management o Older adults with rela...
Update on Basal & Bolus Insulins

Quote of the Day “Everyone knows it requires brains to live long with diabetes, but to use insulin successfully requires more brains” ...
Exendin - A New Incretin?

ADA June 2012 Conference Alpha cells and the origin of glucagon-like sequences and their receptors David M. Irwin, Department of Labo...
Ontario Narcotic Strategy - List of Drugs

By Mary Nelson
Will PPAR Agonist Therapy Survive? The Great Debate!

Yes, by Sr. Steven E. Nissen PPAR Agonists should continue to play an important role in clinical practice - ...
(no title)

Selected Updates in Diabetes Therapeutics from the ACCP 2012 Annual Meeting By Mark Malak, PharmD What do I need to know about Ex...

Hamilton FHT 2011. Watermark theme. Powered by Blogger.